China SXT Pharmaceuticals (SXTC) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q1 2025 value amounting to $2.4 million.
- China SXT Pharmaceuticals' Accumulated Depreciation & Amortization rose 8.92% to $2.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.4 million, marking a year-over-year increase of 8.92%. This contributed to the annual value of $2.4 million for FY2025, which is 8.92% up from last year.
- According to the latest figures from Q1 2025, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization is $2.4 million, which was up 8.92% from $2.4 million recorded in Q1 2024.
- Over the past 5 years, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $2.4 million during Q1 2025, and registered a low of $1.5 million during Q1 2021.
- In the last 5 years, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization had a median value of $1.9 million in 2023 and averaged $2.0 million.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Accumulated Depreciation & Amortization soared by 4215.48% in 2021, and later rose by 8.92% in 2025.
- Quarter analysis of 5 years shows China SXT Pharmaceuticals' Accumulated Depreciation & Amortization stood at $1.5 million in 2021, then increased by 25.0% to $1.8 million in 2022, then increased by 5.58% to $1.9 million in 2023, then increased by 25.97% to $2.4 million in 2024, then increased by 0.09% to $2.4 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $2.4 million for Q1 2025, versus $2.4 million for Q1 2024 and $1.9 million for Q1 2023.